Author | Enzo Galligioni, MD

Articles

Gemcitabine/Epirubicin/Paclitaxel Trials in Advanced Breast Cancer

February 01, 2001

ByPierfranco Conte, MD|Barbara Salvadori, MD|Sara Donati, MD|Alessandra Gennari, MD|Gian Luigi Cetto, MD|Annamaria Molino, MD|Lucio CrinÒ, MD|Francesca Mazzoni, MD|Enzo Galligioni, MD|Maurizio Mansutti, MD

Numerous trials have shown that the pharmacokinetic interferences of epirubicin (Ellence)/paclitaxel (Taxol) combinations produce less pharmacodynamic effect than doxorubicin/paclitaxel regimens. Paclitaxel is more easily